Ecromeximab
Encyclopedia
Ecromeximab is a chimeric
Fusion protein
Fusion proteins or chimeric proteins are proteins created through the joining of two or more genes which originally coded for separate proteins. Translation of this fusion gene results in a single polypeptide with functional properties derived from each of the original proteins...

 monoclonal antibody being developed for the treatment of malignant melanoma.

This drug was developed by Kyowa Hakko Kogyo Co., Ltd.
The source of this article is wikipedia, the free encyclopedia.  The text of this article is licensed under the GFDL.
 
x
OK